| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.18B | — | +12.2% |
| Cost of Revenue | $1.39B | — | +9.3% |
| Gross Profit | $1.79B | — | +14.6% |
| R&D Expense | $588.0M | — | +7.5% |
| SG&A Expense | $284.0M | — | +1.1% |
| Operating Income | $1.50B | — | +108.2% |
| Interest Expense | $114.0M | — | +7.5% |
| Pre-tax Income | $1.41B | — | +123.3% |
| Income Tax | $272.0M | — | +109.2% |
| Net Income | $1.12B | — | +129.0% |
| EPS (Basic) | $4.44 | — | +130.1% |
| EPS (Diluted) | $4.43 | — | +130.7% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.71B | +13.5% | -7.0% |
| Accounts Receivable | $1.19B | +12.4% | +11.9% |
| Inventory | $2.52B | -2.1% | +7.4% |
| Current Assets | $8.15B | +2.7% | +1.6% |
| Total Assets | $27.11B | +2.1% | +7.7% |
| Current Liabilities | $3.64B | -6.3% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $793.0M | — | +40.4% |
| Capital Expenditures | $79.0M | — | -43.2% |
| Investing Cash Flow | $508.0M | — | +335.2% |
| Financing Cash Flow | -$856.0M | — | -348.1% |
| Free Cash Flow | $714.0M | — | +67.6% |
| -5.5% |
| Long-term Debt | $10.97B | -0.6% | +7.3% |
| Total Liabilities | $15.84B | -1.7% | +2.2% |
| Stockholders' Equity | $10.93B | +8.7% | +17.2% |